AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W909. A total of 3 filers reported holding AMICUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,841,000 | +307.6% | 2,350 | +426.9% | 0.36% | +237.0% |
| Q2 2018 | $697,000 | -77.0% | 446 | -77.8% | 0.11% | -40.3% |
| Q1 2018 | $3,024,000 | -79.7% | 2,010 | -80.6% | 0.18% | -86.7% |
| Q4 2017 | $14,924,000 | +139.2% | 10,371 | +150.6% | 1.36% | +233.1% |
| Q3 2017 | $6,240,000 | +25.0% | 4,138 | -16.5% | 0.41% | +24.8% |
| Q2 2017 | $4,993,000 | +60.9% | 4,958 | +13.9% | 0.33% | +95.8% |
| Q1 2017 | $3,104,000 | -38.9% | 4,353 | -57.4% | 0.17% | -43.4% |
| Q4 2016 | $5,077,000 | -28.8% | 10,216 | +6.1% | 0.30% | +10.5% |
| Q3 2016 | $7,128,000 | +63.3% | 9,632 | +20.5% | 0.27% | +17.1% |
| Q2 2016 | $4,364,000 | +114.8% | 7,992 | +232.3% | 0.23% | +123.5% |
| Q1 2016 | $2,032,000 | +20.6% | 2,405 | +38.5% | 0.10% | +9.7% |
| Q4 2015 | $1,685,000 | +65.0% | 1,737 | +137.9% | 0.09% | +121.4% |
| Q3 2015 | $1,021,000 | +14.0% | 730 | +15.3% | 0.04% | +27.3% |
| Q2 2015 | $896,000 | -53.8% | 633 | -64.5% | 0.03% | -59.3% |
| Q1 2015 | $1,941,000 | +327.5% | 1,784 | +226.7% | 0.08% | +478.6% |
| Q4 2014 | $454,000 | – | 546 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 196,800 | $1,879,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 100,500 | $960,000 | 0.00% |
| SIMPLEX TRADING, LLC | 34,500 | $340,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |